Genetic variation in the developmental regulation of cortical avpr1a among prairie voles.

Early experiences can have enduring impacts on brain and behavior, but the strength of these effects can be influenced by genetic variation. In principle, polymorphic CpGs (polyCpGs) may contribute to gene-by-environment interactions (G × E) by altering DNA methylation. In this study, we investigate the influence of polyCpGs on the development of vasopressin receptor 1a abundance in the retrosplenial cortex (RSC-V1aR) of prairie voles (Microtus ochrogaster). Two alternative alleles ('HI'/'LO') predict RSC avpr1a expression, V1aR abundance and sexual fidelity in adulthood; these alleles differ in the frequency of CpG sites and in methylation at a putative intron enhancer. We hypothesized that the elevated CpG abundance in the LO allele would make homozygous LO/LO voles more sensitive to developmental perturbations. We found that genotype differences in RSC-V1aR abundance emerged early in ontogeny and were accompanied by differences in methylation of the putative enhancer. As predicted, postnatal treatment with an oxytocin receptor antagonist (OTA) reduced RSC-V1aR abundance in LO/LO adults but not their HI/HI siblings. Similarly, methylation inhibition by zebularine increased RSC-V1aR in LO/LO adults, but not in HI/HI siblings. These data show a gene-by-environment interaction in RSC-V1aR. Surprisingly, however, neither OTA nor zebularine altered adult methylation of the intronic enhancer, suggesting that differences in sensitivity could not be explained by CpG density at the enhancer alone. Methylated DNA immunoprecipiation-sequencing showed additional differentially methylated regions between HI/HI and LO/LO voles. Future research should examine the role of these regions and other regulatory elements in the ontogeny of RSC-V1aR and its developmentally induced changes.

In vitro enantioselective displacement of propranolol from protein binding sites by acetyl salicylic acid and salicylic acid.

The influences of acetyl salicylic acid (ASA) and salicylic acid (SA) on the enantioselective binding of propranolol (PL) and its enantiomers to plasma proteins and human serum albumin (HSA) were investigated. The equilibrium dialysis was employed for protein binding studies. We observed statistically significant displacement of racemic-PL, (+)-(R)-PL, and (-)-(S)-PL (0.1-10 microM) from their protein binding sites by ASA (200 microg/ml) and SA (100 microg/ml). ASA and SA displaced PL stereoselectivly from its binding sites. We concluded that ASA and its metabolite SA could change R/S ratio of PL unbound fractions and they might affect pharmacokinetic properties of PL.

Molecularly imprinted nano particles combined with miniaturized homogenous liquid-liquid extraction for the selective extraction of loratadine in plasma and urine samples followed by high performance liquid chromatography-photo diode array detection.

In this work a molecularly imprinted polymer was developed as a selective sorbent for extraction of loratadine (as a model) in complex matrices followed by miniaturized homogeneous liquid-liquid extraction (MHLLE) for the first time. The molecularly imprinted polymer (MIP) which is based on loratadine as the template was synthesized successfully by precipitation polymerization and was used as a selective sorbent. This technique was applied for preconcentration, sample preparation, and determination of loratadine using high performance liquid chromatography-photo diode array detection (HPLC-PDA). Optimization of various parameters affecting molecular imprinted solid phase extraction (MISPE), such as pH of adsorption, composition and volume of eluent, adsorption and desorption times were investigated. Besides, in the subsequent stage (MHLLE) the type and volume of extraction solvent, sodium hydroxide amount, surfactant concentration, and extraction time were investigated and optimized. Under the optimal condition, maximum enrichment capacity and Langmuir constant were 91mgg(-1) and 0.014Lmg(-1), respectively. Furthermore, enrichment factor and extraction recovery of MIP-MHLLE method were 30 and 90%, respectively. The LOD of the proposed method was 0.2µgL(-1) and a linear dynamic range of 1-1000µgL(-1) was obtained with correlation coefficient of greater than 0.998. The present method was applied for extraction and determination of loratadine in plasma and urine samples in µgL(-1) levels and satisfactory results were achieved (RSD <8% based on three replicate measurements).